Showing results (111-120 of 182) with videos related to

Sort By:
Pageof 19
Multiple Sclerosis and Related Disorders|December 12, 2018
Multiple sclerosis risk factors contribute to onset heterogeneityFarren B S Briggs, Justin C Yu, Mary F Davis, et al.
Multiple Sclerosis and Related Disorders|October 28, 2018
Comparative effectiveness of dimethyl fumarate versus fingolimod and teriflunomide among MS patients switching from first-generation platform therapies in the USDaniel Ontaneda, Jacqueline Nicholas, Matthew Carraro, et al.
Journal of Intensive Care Medicine|June 11, 2021
Does Targeted Temperature Management Improve Neurological Outcome in Extracorporeal Cardiopulmonary Resuscitation (ECPR)?Merry Huang, Aaron Shoskes, Ibrahim Migdady, et al.
Scientific Reports|November 4, 2016
Structural characterisation of high affinity Siglec-2 (CD22) ligands in complex with whole Burkitt's lymphoma (BL) Daudi cells by NMR spectroscopyPaul D Madge, Andrea Maggioni, Mauro Pascolutti, et al.
Multiple Sclerosis and Related Disorders|December 7, 2016
Comparative efficacy and discontinuation of dimethyl fumarate and fingolimod in clinical practice at 12-month follow-upCarrie M Hersh, Thomas E Love, Samuel Cohn, et al.
Multiple Sclerosis and Related Disorders|April 7, 2022
Association of socioeconomic disadvantage and neighborhood disparities with clinical outcomes in multiple sclerosis patientsJustin R Abbatemarco, Alise Carlson, Daniel Ontaneda, et al.
Multiple Sclerosis Journal - Experimental, Translational and Clinical|June 26, 2019
Exploratory MRI measures after intravenous autologous culture-expanded mesenchymal stem cell transplantation in multiple sclerosisJenny Feng, Erik Offerman, Jian Lin, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|May 20, 2021
Sensitivity of T1/T2-weighted ratio in detection of cortical demyelination is similar to magnetization transfer ratio using post-mortem MRIYufan Zheng, Jessica Dudman, Jacqueline T Chen, et al.
Neurodegenerative Disease Management|January 21, 2025
Real world effectiveness, persistence, tolerability, and safety of ofatumumab in clinical practiceMoein Amin, Tucker Harvey, Dan Michael Pineda, et al.
Multiple Sclerosis Journal - Experimental, Translational and Clinical|November 15, 2019
Serum neurofilament light chain concentration in a phase 1/2 trial of autologous mesenchymal stem cell transplantationLaura E Baldassari, Sarah M Planchon, Robert A Bermel, et al.
Pageof 19